Home  »  Industry   »  Bristol-Myers Squibb Company (BMY) can’t be writ...

Bristol-Myers Squibb Company (BMY) can’t be written off after posting last 3-months Average volume of 9.77M

For the readers interested in the stock health of Bristol-Myers Squibb Company (BMY). It is currently valued at $71.29. When the transactions were called off in the previous session, Stock hit the highs of $71.875, after setting-off with the price of $69.20. Company’s stock value dipped to $69.20 during the trading on the day. When the trading was stopped its value was $69.46.Recently in News on September 20, 2022, Keep the Wheels Turning. By Karin Shanahan, Executive Vice President, Global Product Development and Supply. You can read further details here

Bristol-Myers Squibb Company had a pretty favorable run when it comes to the market performance. The 1-year high price for the company’s stock is recorded $80.59 on 06/27/22, with the lowest value was $60.86 for the same time period, recorded on 01/06/22.

Top 5 Cheap Stocks to Own Right Now

While finding safe stocks with the potential for monster gains isn't always easy, we've found a few that could pay out well. In fact, within our report, "Top 5 Cheap Stock to Own Right Now", we have identified five stocks we believe could appreciate the most even if you just have $1,000 to invest.

Sign up here to get your free report now. .


Bristol-Myers Squibb Company (BMY) full year performance was 18.52%

Price records that include history of low and high prices in the period of 52 weeks can tell a lot about the stock’s existing status and the future performance. Presently, Bristol-Myers Squibb Company shares are logging -11.54% during the 52-week period from high price, and 33.95% higher than the lowest price point for the same timeframe. The stock’s price range for the 52-week period managed to maintain the performance between $53.22 and $80.59.

The company’s shares, operating in the sector of Healthcare managed to top a trading volume set approximately around 9992144 for the day, which was evidently higher, when compared to the average daily volumes of the shares.

When it comes to the year-to-date metrics, the Bristol-Myers Squibb Company (BMY) recorded performance in the market was 14.34%, having the revenues showcasing -8.24% on a quarterly basis in comparison with the same period year before. At the time of this writing, the total market value of the company is set at 152.78B, as it employees total of 32200 workers.

The Analysts eye on Bristol-Myers Squibb Company (BMY)

According to the data provided on Barchart.com, the moving average of the company in the 100-day period was set at 74.15, with a change in the price was noted -3.98. In a similar fashion, Bristol-Myers Squibb Company posted a movement of -5.29% for the period of last 100 days, recording 11,668,171 in trading volumes.

Total Debt to Equity Ratio (D/E) can also provide valuable insight into the company’s financial health and market status. The debt to equity ratio can be calculated by dividing the present total liabilities of a company by shareholders’ equity. Debt to Equity thus makes a valuable metrics that describes the debt, company is using in order to support assets, correlating with the value of shareholders’ equity The total Debt to Equity ratio for BMY is recording 1.29 at the time of this writing. In addition, long term Debt to Equity ratio is set at 1.14.

Technical rundown of Bristol-Myers Squibb Company (BMY)

Raw Stochastic average of Bristol-Myers Squibb Company in the period of last 50 days is set at 53.19%. The result represents improvement in oppose to Raw Stochastic average for the period of the last 20 days, recording 53.19%. In the last 20 days, the company’s Stochastic %K was 41.93% and its Stochastic %D was recorded 41.78%.

Considering, the past performance of Bristol-Myers Squibb Company, multiple moving trends are noted. Year-to-date Price performance of the company’s stock appears to be pessimistic, given the fact the metric is recording 14.34%. Additionally, trading for the stock in the period of the last six months notably deteriorated by -0.13%, alongside a boost of 18.52% for the period of the last 12 months. The shares increased approximately by -0.68% in the 7-day charts and went up by -2.03% in the period of the last 30 days. Common stock shares were lifted by -8.24% during last recorded quarter.

Leave a Comment

Your email address will not be published.

On Key

Related Posts